These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18071042)

  • 1. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
    Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ
    Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
    Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
    J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine receptors in the retinas of the α7 nicotinic acetylcholine receptor knockout mouse.
    Smith ML; Souza FG; Bruce KS; Strang CE; Morley BJ; Keyser KT
    Mol Vis; 2014; 20():1328-56. PubMed ID: 25352741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD; Wecker L; Abrahamson EE; Wuu J; Counts SE; Ginsberg SD; Mufson EJ; Dekosky ST
    Arch Neurol; 2009 May; 66(5):646-51. PubMed ID: 19433665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
    Counts SE; Che S; Ginsberg SD; Mufson EJ
    J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of alpha7 and beta2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons.
    Azam L; Winzer-Serhan U; Leslie FM
    Neuroscience; 2003; 119(4):965-77. PubMed ID: 12831856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
    Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
    J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Oligomeric Amyloid-Beta (oAβ
    George AA; Vieira JM; Xavier-Jackson C; Gee MT; Cirrito JR; Bimonte-Nelson HA; Picciotto MR; Lukas RJ; Whiteaker P
    J Neurosci; 2021 Jan; 41(3):555-575. PubMed ID: 33239400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein.
    Wevers A; Monteggia L; Nowacki S; Bloch W; Schütz U; Lindstrom J; Pereira EF; Eisenberg H; Giacobini E; de Vos RA; Steur EN; Maelicke A; Albuquerque EX; Schröder H
    Eur J Neurosci; 1999 Jul; 11(7):2551-65. PubMed ID: 10383644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q; Xie X; Emadi S; Sierks MR; Wu J
    Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease.
    Counts SE; Chen EY; Che S; Ikonomovic MD; Wuu J; Ginsberg SD; Dekosky ST; Mufson EJ
    Dement Geriatr Cogn Disord; 2006; 21(4):205-14. PubMed ID: 16410678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
    Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
    Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
    Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL
    Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
    Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
    Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Che S; Counts SE; Mufson EJ
    J Neurochem; 2006 Mar; 96(5):1401-8. PubMed ID: 16478530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.